Livmarli (maralixibat)

£56,240.00

Livmarli (maralixibat) is an oral solution to treat cholestatic pruritus in patients with Alagille syndrome (ALGS) 1 year of age and older.

DISEASE INDICATIONS

Alagille syndrome

MANUFACTURER

Mirum Pharmaceuticals

USAGE

Oral

MEDICINE APPROVED BY

  • European Medical Agency (EMA)

  • Food and Drug Administration (FDA)

    PATIENTS HELPED

    • Over 1.2 million patients reached

    • More than 11,000 patients helped

    • 100% successful deliveries to 88 countries

This content has been reviewed by a Medical Doctor.
Shopping Cart

No products in the cart.